Compare VYGR & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYGR | TRAK |
|---|---|---|
| Founded | 2013 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.0M | 212.5M |
| IPO Year | 2015 | 1996 |
| Metric | VYGR | TRAK |
|---|---|---|
| Price | $3.79 | $8.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 527.4K | 75.6K |
| Earning Date | 01-01-0001 | 06-08-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | ★ 20.69 |
| EPS | N/A | ★ 0.18 |
| Revenue | $10,135,000.00 | ★ $21,007,076.00 |
| Revenue This Year | N/A | $8.29 |
| Revenue Next Year | $71.77 | $24.17 |
| P/E Ratio | ★ N/A | $46.56 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $2.65 | $8.38 |
| 52 Week High | $5.55 | $23.72 |
| Indicator | VYGR | TRAK |
|---|---|---|
| Relative Strength Index (RSI) | 47.48 | 19.08 |
| Support Level | $2.79 | N/A |
| Resistance Level | $3.73 | $10.75 |
| Average True Range (ATR) | 0.21 | 0.42 |
| MACD | 0.00 | -0.15 |
| Stochastic Oscillator | 54.65 | 0.00 |
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.